Philips seeks FDA clearance for new 'helium-free' 3T MRI scanner
Philips has submitted its BlueSeal Horizon SI, XI and ZI 3T MRI systems to the Food and Drug Administration for 510(k) clearance, according to a Tuesday announcement.
The move is intended to advance the company’s efforts to expand helium-free technology in the United States. The BlueSeal Horizon platform grows Philips' helium-free MRI portfolio from 1.5T to 3T. The new imaging systems combine the company's sealed magnet technology with new features and advanced clinical AI applications designed to support multiple specialties.
Traditional MRI systems rely on liquid helium to cool superconducting magnets, requiring infrastructure specifications like helium vent pipes and periodic consideration of helium supply. Philips' technology uses a sealed magnet design that substantially reduces the amount of liquid helium required and eliminates the need for routine helium refills. The technology also is designed to reduce installation complexity and lifecycle risks associated with helium-dependent systems.
The move to 3T extends those potential infrastructure benefits to higher-field MRI, which can support advanced imaging applications and more complex clinical protocols. Philips said BlueSeal Horizon incorporates next-generation AI solutions intended to help radiology teams manage demand while maintaining performance.
“The FDA submission of BlueSeal Horizon marks an important step toward bringing the benefits of helium-free 3T MRI to more healthcare providers and patients,” Ioannis Panagiotelis, PhD, business leader for MR at Philips, said in an announcement.
The systems remain under FDA review and are not yet cleared for U.S. marketing. The submission represents the next regulatory step in Philips' expansion of its helium-free MRI technology. The company first introduced its BlueSeal 1.5T systems in 2018. More than 2,500 are now installed worldwide, collectively saving more than 7 million liters of liquid helium, according to the company.
Read more here.
